title: Clinical efficacy and toxiciy of gefitinib in patients with lung cancer.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mitsui
authors.forename: Jun
authors.initials: J
authors.lastname: Nakajima
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Maruyama
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Hanajiri
authors.forename: Masao
authors.initials: M
authors.lastname: Omata
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001201:Ascites / Q000139:chemically induced*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D000077156:Gefitinib; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D034141:Hypoalbuminemia / Q000139:chemically induced*; D008103:Liver Cirrhosis / Q000150:complications; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib